S. Chatur

发表

Incidence of Syncope During Pregnancy: Temporal Trends and Outcomes

R. Sandhu, P. Kaul, R. Sheldon, 2019, Journal of the American Heart Association.

Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF

S. Solomon, M. Pfeffer, J. McMurray, 2022, European journal of heart failure.

How to Diagnose and Manage Radiation Cardiotoxicity

S. Ganatra, A. Nohria, S. Chatur, 2020, JACC. CardioOncology.

Inhibition of vascular endothelial growth factor reduces cardiac allograft vasculopathy.

B. McManus, B. Wong, J. Carthy, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial

Akshay S. Desai, M. Pfeffer, J. McMurray, 2022, European journal of heart failure.

RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.

N. Wong, J. Genest, G. Wagner, 2010, Journal of the American College of Cardiology.

Random admission urinary sodium for diuretic response: promise in pragmatism?

N. Lakdawala, J. Cunningham, S. Chatur, 2022, European journal of heart failure.

Burden of Valvular Heart Disease in Patients with Fabry Disease.

N. Fine, Aneal Khan, R. Hopkin, 2021, Journal of the American Society of Echocardiography.

Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial

M. Pfeffer, J. McMurray, M. Vaduganathan, 2022, European journal of heart failure.

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.

Akshay S. Desai, J. McMurray, P. Jhund, 2023, European heart journal.

Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial

Akshay S. Desai, J. McMurray, P. Jhund, 2023, European journal of heart failure.

Give a nudge a shot: NUDGE‐FLU bridging the cardiovascular quality chasm

J. Ezekowitz, S. Chatur, 2023, European journal of heart failure.

Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure.

M. Pfeffer, J. McMurray, J. Rouleau, 2023, Journal of the American College of Cardiology.

Monitoring treatment with cardiac myosin inhibitors in symptomatic obstructive hypertrophic cardiomyopathy

S. Chatur, Sheila M. Hegde, 2023, Current opinion in cardiology.

Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study.

P. Gordan, M. Vaduganathan, N. Choudhry, 2023, Journal of the American College of Cardiology.

Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial

P. Jhund, M. Vaduganathan, M. Kosiborod, 2023, European journal of heart failure.

Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season.

T. Biering-Sørensen, M. Vaduganathan, K. Janstrup, 2024, American heart journal.